UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6600) 6600
Newspaper Article (526) 526
Newsletter (131) 131
Book Chapter (36) 36
Magazine Article (14) 14
Web Resource (4) 4
Book / eBook (2) 2
Publication (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5101) 5101
science & technology (4865) 4865
life sciences & biomedicine (4478) 4478
neutropenia (4079) 4079
female (3196) 3196
male (3076) 3076
adult (2016) 2016
middle aged (1926) 1926
hematology (1707) 1707
immunology (1695) 1695
oncology (1613) 1613
aged (1405) 1405
neutropenia - immunology (1175) 1175
chemotherapy (1157) 1157
neutropenia - chemically induced (1070) 1070
cancer (1001) 1001
infectious diseases (993) 993
adolescent (987) 987
patients (982) 982
neutropenia - complications (957) 957
animals (892) 892
infections (862) 862
child (859) 859
treatment outcome (795) 795
neutropenia - etiology (746) 746
neutrophils (727) 727
child, preschool (704) 704
abridged index medicus (697) 697
pediatrics (690) 690
risk factors (647) 647
microbiology (645) 645
research (638) 638
infant (621) 621
neutropenia - drug therapy (604) 604
care and treatment (599) 599
transplantation (597) 597
neutrophils - immunology (572) 572
health aspects (569) 569
retrospective studies (540) 540
leukemia (506) 506
bone marrow (504) 504
medicine (499) 499
fever (483) 483
research article (464) 464
antineoplastic combined chemotherapy protocols - therapeutic use (456) 456
mice (454) 454
analysis (435) 435
clinical trials (434) 434
cancer therapies (431) 431
blood (429) 429
antineoplastic combined chemotherapy protocols - adverse effects (423) 423
stem cells (419) 419
medical research (417) 417
leukocyte count (413) 413
mortality (410) 410
drug therapy (398) 398
neutropenia - therapy (392) 392
antineoplastic agents - adverse effects (391) 391
granulocyte colony-stimulating factor - therapeutic use (390) 390
antibiotics (387) 387
science & technology - other topics (385) 385
multidisciplinary sciences (384) 384
mutation (384) 384
immunocompromised host (383) 383
aged, 80 and over (376) 376
toxicity (376) 376
prospective studies (369) 369
leukocytes (358) 358
science (347) 347
drug dosages (342) 342
granulocyte colony-stimulating factor (340) 340
young adult (340) 340
infant, newborn (331) 331
anemia (329) 329
granulocytes (318) 318
anti-bacterial agents - therapeutic use (316) 316
neutropenia - blood (316) 316
infection (313) 313
pharmacology & pharmacy (311) 311
general & internal medicine (306) 306
children (304) 304
neutropenia - genetics (292) 292
neoplasms - complications (285) 285
time factors (284) 284
thrombocytopenia (281) 281
neutropenia - diagnosis (279) 279
medicine, general & internal (272) 272
antifungal agents - therapeutic use (271) 271
medicine & public health (266) 266
lymphomas (260) 260
studies (258) 258
prognosis (257) 257
neutropenia - pathology (255) 255
hospitals (253) 253
drug administration schedule (251) 251
hematopoietic stem cells (251) 251
diagnosis (249) 249
neoplasms - drug therapy (249) 249
proteins (248) 248
metastasis (243) 243
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7023) 7023
French (78) 78
Japanese (65) 65
German (58) 58
Spanish (56) 56
Russian (26) 26
Chinese (22) 22
Polish (17) 17
Italian (13) 13
Portuguese (10) 10
Dutch (8) 8
Hungarian (8) 8
Norwegian (7) 7
Czech (6) 6
Danish (6) 6
Turkish (4) 4
Swedish (3) 3
Croatian (2) 2
Finnish (2) 2
Hebrew (2) 2
Korean (1) 1
Persian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of hematology, ISSN 0939-5555, 2/2018, Volume 97, Issue 2, pp. 309 - 317
This retrospective study attempts to establish if a correlation exists between osteoporosis and hematopoiesis before and after adjuvant chemotherapy in the... 
T-score | Hematology | TBS | Anemia | Bone marrow microenvironment | Oncology | Breast cancer | Graded toxicity of chemotherapy | Osteoporosis | Chemotherapy | Platelet | Medicine & Public Health | Trabecular bone score | Hematopoiesis | Stress hematopoiesis | Osteoblast | Neutrophil | Bone marrow adipocytes | Febrile neutropenia | Life Sciences & Biomedicine | Science & Technology | Blood Platelets - immunology | Bone Density - immunology | Breast Neoplasms - immunology | Cell Count | Humans | Middle Aged | Adipocytes - drug effects | Antineoplastic Agents - administration & dosage | Hematopoiesis - drug effects | Bone Diseases, Metabolic - drug therapy | Bone Diseases, Metabolic - complications | Bone Marrow Cells - immunology | Osteoporosis - diagnostic imaging | Chemotherapy, Adjuvant | Neutropenia - immunology | Body Mass Index | Osteoporosis - immunology | Lumbar Vertebrae - diagnostic imaging | Neutrophils - drug effects | Bone Marrow Cells - pathology | Lumbar Vertebrae - drug effects | Absorptiometry, Photon | Breast Neoplasms - drug therapy | Hematopoiesis - immunology | Neutropenia - diagnostic imaging | Lumbar Vertebrae - pathology | Blood Platelets - pathology | Osteoporosis - drug therapy | Antineoplastic Agents - adverse effects | Neutropenia - pathology | Adult | Bone Marrow Cells - drug effects | Female | Retrospective Studies | Breast Neoplasms - diagnostic imaging | Blood Platelets - drug effects | Neutropenia - chemically induced | Adipocytes - immunology | Neutrophils - pathology | Bone Diseases, Metabolic - diagnostic imaging | Bone Diseases, Metabolic - immunology | Osteoblasts - drug effects | Neutrophils - immunology | Osteoblasts - immunology | Lumbar Vertebrae - immunology | Adipocytes - pathology | Breast Neoplasms - complications | Osteoblasts - pathology | Bone Density - drug effects | Osteoporosis - complications | Aged | Oncology, Experimental | Adjuvant treatment | Research | Cancer | Neutrophils | Index Medicus | Original
Journal Article
Blood, ISSN 0006-4971, 04/2006, Volume 107, Issue 8, pp. 3045 - 3052
Journal Article
Journal Article
Respirology (Carlton, Vic.), ISSN 1323-7799, 08/2010, Volume 15, Issue 7, pp. 1037 - 1056
ABSTRACT Lung infections caused by the opportunistic pathogen Pseudomonas aeruginosa can present as a spectrum of clinical entities from a rapidly fatal... 
Pseudomonas aeruginosa | innate immunity | biofilm | respiratory infection | mucosal immunity | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Pseudomonas aeruginosa - immunology | Pulmonary Disease, Chronic Obstructive - microbiology | Receptors, Pattern Recognition - immunology | Lung Diseases - microbiology | Humans | Virulence Factors - immunology | Cross Infection - immunology | Bronchiectasis - immunology | Cystic Fibrosis - immunology | Leukocytes - immunology | Cross Infection - pathology | Pseudomonas aeruginosa - pathogenicity | Leukocytes - microbiology | Immunologic Deficiency Syndromes - immunology | Cytokines - immunology | Bronchiolitis Obliterans - microbiology | Cystic Fibrosis - microbiology | Bronchiolitis Obliterans - immunology | Bronchiectasis - microbiology | Immunologic Deficiency Syndromes - microbiology | Pseudomonas Infections - microbiology | Mucus - microbiology | Pseudomonas Infections - immunology | Host-Pathogen Interactions | Lung Diseases - immunology | Animals | Biofilms | Cross Infection - microbiology | Pseudomonas Infections - pathology | Mice | Mucus - immunology | Lung Diseases - pathology | Pulmonary Disease, Chronic Obstructive - immunology | Development and progression | Cystic fibrosis | Pneumonia | Analysis | Bacterial pneumonia | Index Medicus | Pathogens | Immune response | Lung diseases | Mechanical properties | Opportunist infection | Environmental factors | Leukocytes (neutrophilic) | Mucus | virulence factors | Infection | Nutrients | Bronchitis | Models | Neutropenia
Journal Article
British journal of haematology, ISSN 1365-2141, 02/2019, Volume 185, Issue 2, pp. 240 - 253
Summary Chemotherapy plus rituximab has been the mainstay of treatment for follicular lymphoma (FL) for two decades but is associated with immunosuppression... 
immunomodulation | non‐Hodgkin lymphoma | antibody‐dependent cell‐mediated cytotoxicity | lenalidomide | follicular lymphoma | non-Hodgkin lymphoma | antibody-dependent cell-mediated cytotoxicity | Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Immunotherapy - methods | Lymphoma, Follicular - drug therapy | Humans | Antibody-Dependent Cell Cytotoxicity - immunology | Cyclophosphamide - therapeutic use | Rituximab - therapeutic use | Lymphocyte Activation - immunology | Killer Cells, Natural - immunology | Tumor Cells, Cultured | Neutrophils - drug effects | Drug Resistance, Neoplasm - immunology | Rituximab - administration & dosage | B-Lymphocytes - drug effects | Lenalidomide - administration & dosage | Immunological Synapses - drug effects | Lenalidomide - immunology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphocyte Activation - drug effects | CD8-Positive T-Lymphocytes - drug effects | Immunological Synapses - immunology | Vincristine - therapeutic use | Lymphocyte Count | Cell Proliferation - drug effects | Killer Cells, Natural - drug effects | Rituximab - immunology | Antibody-Dependent Cell Cytotoxicity - drug effects | CD8-Positive T-Lymphocytes - immunology | Cytokines - biosynthesis | Prednisone - therapeutic use | Antimitotic agents | Viral antibodies | Killer cells | Chemotherapy | Cell death | Analysis | Immunotherapy | Antibodies | Lymphomas | Biochemistry | Antineoplastic agents | Cancer | Toxicity | Rituximab | Cytotoxicity | Immunological synapses | Lymphocytes T | Lymphoma | Immunity | Patients | Immunosuppression | Immunology | Natural killer cells | Synapses | Tumors | Neutropenia | Index Medicus | Life Sciences | Human health and pathology | Haematological Malignancy | Research Paper
Journal Article